November 29, 2016 HAYWARD, Calif.–(BUSINESS WIRE)–Moximed®, Inc. announced today that the first patient has been treated in an FDA-approved IDE study for its latest generation unicompartmental unloading implant, the Atlas System. The Atlas System builds on the company’s eight years of clinical success with joint unloading implants for medial knee osteoarthritis (OA). “I’m pleased to […]

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone